Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients.
cardiovascular disease
cirrhosis
clinical research / practice
comorbidities
heart disease
liver disease
liver transplantation/hepatology
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
27
11
2019
revised:
30
03
2020
accepted:
10
04
2020
pubmed:
30
4
2020
medline:
22
6
2021
entrez:
30
4
2020
Statut:
ppublish
Résumé
Severe aortic stenosis is a widespread valve disease, constituting a contraindication to organ transplantation due to cardiovascular morbidity and projected mortality. Mortality after conventional surgical aortic valve replacement in cirrhotic patients depends upon the Child-Pugh class. In the past few years, transcatheter aortic valve replacement has progressively become the treatment of choice for high-risk patients with severe aortic stenosis. Here, we report the cases of 3 cirrhotic patients who became eligible for liver transplantation after successful transcatheter aortic valve replacement as bridge therapy.
Identifiants
pubmed: 32347626
doi: 10.1111/ajt.15955
pii: S1600-6135(22)22574-X
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2567-2570Informations de copyright
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
EASL Clinical Practice Guidelines. Liver transplantation. J Hepatol. 2016;64(2):433-485.
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J - Cardiovascular Imaging. 2017;18(3):254-275.
Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82(6):2111-2115.
Chitsaz S, Jaussaud N, Chau E, et al. Operative risks and survival in veterans with severe aortic stenosis: surgery versus medical therapy. Ann Thorac Surg. 2011;92(3):866-872.
Steffen RJ, Bakaeen FG, Vargo PR, et al. Impact of cirrhosis in patients who underwent surgical aortic valve replacement. Am J Cardiol. 2017;120(4):648-654.
Filsoufi F, Salzberg SP, Rahmanian PB, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl. 2007;13(7):990-995.
Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162-172.
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609-1620.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.
Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. The Lancet. 2016;387(10034):2218-2225.
Silvestre OM, Bacal F, Ramos DS, et al. Transcatheter aortic valve implantation as rescue therapy for liver transplant candidates with aortic valve stenosis. Liver Transpl. 2014;20(10):1277-1279.
Wilkey BJ, Hanson R, Reece TB, et al. Transfemoral transcatheter aortic valve replacement for mixed aortic valve disease in child's class C liver disease prior to orthotopic liver transplantation: a case report. Semin Cardiothorac Vasc Anesth. 2016;20(2):158-162.
Cabasa AS, Eleid MF, Suri RM. Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation. Catheter Cardiovasc Interv. 2016;88(4):665-670.
Kaliamoorthy I, Rajakumar A, Living VJ, et al. Living donor liver transplantation following transcatheter aortic valve implantation for aortic valvular disease. Seminars Cardiothoracic Vascular Anesthesia. 2019;108925321988716. https://doi.org/10.1177/1089253219887162. [Epub ahead of print].
Büttner S, Weiler H, Zöller C, et al. Aortic valve stenosis in a dialysis patient waitlisted for kidney transplantation. Annals Thoracic Surgery. 2016;102(5):437-438.
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
Yassin AS, Subahi A, Abubakar H, et al. Outcomes and effects of hepatic cirrhosis in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2018;122(3):455-460.
Intagliata NM, Argo CK, Stine JG, et al. Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference. Thrombosis Haemostasis. 2018;118(08):1491-1506.
Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799-809.
Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58(3):223-231.